Schwab Charles Investment Management Inc. raised its holdings in shares of Cantel Medical Corp. (NYSE:CMD) by 4.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 198,741 shares of the company’s stock after acquiring an additional 9,021 shares during the quarter. Schwab Charles Investment Management Inc. owned approximately 0.48% of Cantel Medical worth $18,716,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the company. BlackRock Inc. acquired a new stake in Cantel Medical during the 2nd quarter valued at $376,271,000. Vanguard Group Inc. acquired a new stake in Cantel Medical during the 2nd quarter valued at $246,860,000. Neuberger Berman Group LLC acquired a new stake in Cantel Medical during the 2nd quarter valued at $96,236,000. Dimensional Fund Advisors LP acquired a new stake in Cantel Medical during the 2nd quarter valued at $75,756,000. Finally, Wells Fargo & Company MN acquired a new stake in Cantel Medical during the 2nd quarter valued at $75,715,000. 84.67% of the stock is owned by institutional investors.

In other news, Chairman Charles M. Diker sold 20,500 shares of Cantel Medical stock in a transaction on Wednesday, October 4th. The stock was sold at an average price of $99.15, for a total transaction of $2,032,575.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Eric W. Nodiff sold 2,868 shares of Cantel Medical stock in a transaction on Friday, October 20th. The stock was sold at an average price of $97.55, for a total value of $279,773.40. Following the sale, the executive vice president now directly owns 39,102 shares of the company’s stock, valued at approximately $3,814,400.10. The disclosure for this sale can be found here. Insiders have sold 36,368 shares of company stock valued at $3,576,028 in the last three months. Insiders own 12.30% of the company’s stock.

Shares of Cantel Medical Corp. (NYSE CMD) opened at $99.34 on Wednesday. Cantel Medical Corp. has a twelve month low of $69.21 and a twelve month high of $108.00. The stock has a market capitalization of $4,183.09, a price-to-earnings ratio of 46.76 and a beta of 1.24. The company has a current ratio of 2.44, a quick ratio of 1.48 and a debt-to-equity ratio of 0.31.

Cantel Medical (NYSE:CMD) last announced its quarterly earnings results on Thursday, September 28th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.02. Cantel Medical had a return on equity of 17.42% and a net margin of 9.50%. The business had revenue of $205.50 million during the quarter, compared to the consensus estimate of $200.32 million. The company’s quarterly revenue was up 14.8% compared to the same quarter last year. equities research analysts expect that Cantel Medical Corp. will post 2.35 earnings per share for the current fiscal year.

The company also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Wednesday, January 17th will be issued a dividend of $0.085 per share. The ex-dividend date of this dividend is Tuesday, January 16th. This represents a dividend yield of 0.17%. This is an increase from Cantel Medical’s previous Semi-Annual dividend of $0.07. Cantel Medical’s dividend payout ratio (DPR) is currently 7.73%.

Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical in a report on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $87.50.

TRADEMARK VIOLATION WARNING: “Schwab Charles Investment Management Inc. Raises Stake in Cantel Medical Corp. (CMD)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.watchlistnews.com/schwab-charles-investment-management-inc-raises-stake-in-cantel-medical-corp-cmd/1774459.html.

Cantel Medical Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Institutional Ownership by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.